61.23
Finanzdaten der Cytokinetics Inc-Aktie (CYTK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
47.89%
28.62
|
19.36 | 17.75 | 1.936 | 66.77 |
|
|
2.38%
207.80
|
202.97 | 196.12 | 168.69 | 178.28 |
| Operating Income/Loss |
2.42%
-179.17
|
-183.62 | -178.37 | -166.75 | -111.51 |
| Nonoperating Income/Loss |
26.48%
13.94
|
11.02 | 11.47 | 10.25 | 13.00 |
| Net Income/Loss |
3.53%
-198.76
|
-206.03 | -183.03 | -306.18 | -134.37 |
| Basic Average Shares |
7.15%
0.1321
|
0.1233 | 0.000786 | 0.12 | 0.1195 |
| Diluted Average Shares |
7.15%
0.1321
|
0.1233 | 0.000786 | 0.12 | 0.1195 |
| Basic Earnings Per Share |
10.18%
-1.50
|
-1.67 | -1.50 | -2.55 | -1.12 |
| Diluted Earnings Per Share |
10.18%
-1.50
|
-1.67 | -1.50 | -2.55 | -1.12 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):